azacitidine and B-Cell Chronic Lymphocytic Leukemia

azacitidine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.00)18.2507
2000's7 (28.00)29.6817
2010's17 (68.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albano, F; Anelli, L; Brunetti, C; Carluccio, P; Casieri, P; Coccaro, N; Cumbo, C; Impera, L; Minervini, A; Minervini, CF; Orsini, P; Parciante, E; Ricco, A; Specchia, G; Tota, G; Zagaria, A1
Berger, F; Bertoni, F; Cavalli, F; Cogliatti, S; Forconi, F; Gaidano, G; Gattei, V; Kwee, I; Lucioni, M; Marasca, R; Mensah, AA; Orlandi, EM; Rinaldi, A; Rossi, D; Zucca, E1
Benedetti, D; Bomben, R; Caldana, C; D'Arena, G; Dal Bo, M; Del Poeta, G; Di Raimondo, F; Gaidano, G; Gattei, V; Hartmann, TN; Hutterer, E; Pozzato, G; Pozzo, F; Rossi, D; Rossi, FM; Tissino, E; Zaja, F; Zucchetto, A1
Chim, CS; Jin, DY; Kho, CS; Kwong, YL; Rosèn, A; Tse, E; Wang, LQ; Wong, KF1
Ali, D; Bengtzen, S; Deneberg, S; Kanduri, M; Karimi, M; Kimby, E; Lehmann, S; Lennartsson, A; Mansouri, L; Qu, Y; Rosenquist, R1
Chim, CS; Rosèn, A; Wang, LQ; Wong, KY1
Chim, CS; Li, ZH; Wang, LQ; Wong, KY1
Fonte, E; Ghia, P; Muzio, M; Ntoufa, S; Papakonstantinou, N; Ranghetti, P; Scarfò, L; Stamatopoulos, K; Tocchetti, M; Veliz Rodriguez, T; Vilia, MG1
Dubovsky, JA; Gordon, J; McNeel, DG; Pinilla-Ibarz, JA; Powers, JJ; Sotomayor, EM1
Bandzuchova, E; Demitrovicova, L; Mistrik, M; Polakova, K; Russ, G; Sabty, FA1
Andritsos, L; Baiocchi, R; Benson, DM; Blum, KA; Byrd, JC; Chan, KK; Chen, P; Devine, SM; Flynn, J; Grever, MR; Jones, J; Liu, Z; Lucas, DM; Marcucci, G; Plass, C; Xie, Z1
Bauer, K; Brillant, C; Engert, A; Herbst, C; Kluge, S; Monsef, I; Skoetz, N1
Berchmans, E; Dubovsky, JA; Pinilla-Ibarz, JA; Powers, JJ; Smith, MA; Sotomayor, EM; Wang, D; Wright, KL1
Dubovsky, JA; Gao, Y; Mariusso, LF; Pinilla-Ibarz, JA; Powers, JJ; Sotomayor, EM1
Chim, CS; Chung, LP; Jin, DY; Lam, WW; Li, GK; Liang, R; Loong, F; So, CC; Wong, KY1
Amin, S; Mann, D; Mann, J; Oscier, D; Parker, AE; Walsh, M; Willmore, E; Wilson, C1
Agarwal, P; Axelsson, T; Ehrencrona, H; Göransson, H; Halldórsdóttir, AM; Isaksson, A; Jernberg-Wiklund, H; Kanduri, M; Mansouri, L; Marincevic, M; Rosenquist, R; Sander, B; Stamatopoulos, K1
Gladkikh, AA; Hoheisel, JD; Joos, TO; Kalashnikova, OB; Kaplanov, KD; Luckert, K; Mastitsky, SE; Moskalev, EA; Pötz, O; Schrenk, M; Stephan, A; Vorobjev, IA1
Bickel, S; Cortes, J; Estrov, Z; Garcia-Manero, G; Keating, MJ; Malik, A; Shoukier, M; Wierda, W1
Bennett, KL; Byrd, JC; Grever, MR; Kipps, TJ; Liyanarachchi, S; Lucas, DM; Matkovic, JJ; Plass, C; Rassenti, L; Raval, A; Young, DC1
Byrd, JC; Issa, JP1
Byrd, JC; Chen, SS; Liu, TH; Matkovic, JJ; Plass, C; Raval, A1
Akao, Y; Kinoshita, T; Kitade, Y; Nakagawa, Y; Naoe, T1
deSilva, M; El-Osta, A; Hu, XF; Kantharidis, P; Nadalin, G; Parkin, JD; Slater, A; Wall, DM; Zalcberg, JR1
Depil, S; Dussart, P; Prin, L; Roche, C1

Reviews

1 review(s) available for azacitidine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Decitabine in chronic leukemias.
    Seminars in hematology, 2005, Volume: 42, Issue:3 Suppl 2

    Topics: Azacitidine; Chronic Disease; Combined Modality Therapy; Decitabine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive

2005

Trials

2 trial(s) available for azacitidine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.
    British journal of haematology, 2010, Volume: 150, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Thrombocytopenia; Treatment Outcome

2010
Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study.
    Clinical lymphoma, myeloma & leukemia, 2013, Volume: 13, Issue:3

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; DNA Methylation; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Treatment Outcome

2013

Other Studies

22 other study(ies) available for azacitidine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.
    Diagnostic pathology, 2018, Dec-22, Volume: 13, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alu Elements; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Feasibility Studies; Female; Genetic Predisposition to Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies

2018
Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
    British journal of haematology, 2013, Volume: 163, Issue:2

    Topics: Azacitidine; Cell Cycle; Cell Transformation, Neoplastic; Cluster Analysis; Decitabine; Disease Progression; DNA Methylation; Epigenesis, Genetic; Epigenomics; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplastic Stem Cells; Oncostatin M; Promoter Regions, Genetic; Reproducibility of Results

2013
CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
    Blood, 2013, Nov-07, Volume: 122, Issue:19

    Topics: Azacitidine; B-Lymphocytes; Cell Proliferation; Cells, Cultured; Chromosomes, Human, Pair 12; Decitabine; Disease Progression; Gene Expression Regulation, Leukemic; Humans; Integrin alpha4; Leukemia, Lymphocytic, Chronic, B-Cell; Methylation; Sequence Analysis, DNA; Signal Transduction; Survival Analysis; Trisomy

2013
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Journal of translational medicine, 2014, Feb-22, Volume: 12

    Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Blood Cells; Bone Marrow Cells; Cell Line, Tumor; Death-Associated Protein Kinases; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; MicroRNAs; Middle Aged; Polymerase Chain Reaction

2014
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.
    Epigenetics, 2014, Volume: 9, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Cycle Proteins; Chromosomes, Human, Pair 11; Cohort Studies; Female; Gene Deletion; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylation; MicroRNAs; Middle Aged; Promoter Regions, Genetic

2014
Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Oncotarget, 2015, Dec-29, Volume: 6, Issue:42

    Topics: 3' Untranslated Regions; Adult; Aged; Aged, 80 and over; Apoptosis; Asian People; Azacitidine; Binding Sites; Cell Line, Tumor; Cell Proliferation; China; Death Domain Receptor Signaling Adaptor Proteins; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Activation; Enzyme Inhibitors; Epigenesis, Genetic; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Guanine Nucleotide Exchange Factors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; MicroRNAs; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA Interference; Signal Transduction; Transfection

2015
Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Oncotarget, 2016, Dec-13, Volume: 7, Issue:50

    Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Azacitidine; Case-Control Studies; Caspase 9; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; MicroRNAs; Middle Aged; Neoplasm Staging; Promoter Regions, Genetic; RNA, Long Noncoding; Transfection

2016
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:10

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Disease Models, Animal; DNA Methylation; Humans; Inflammation; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Receptors, Interleukin-1

2017
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

    Topics: Adult; Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; B7-1 Antigen; B7-2 Antigen; Blotting, Western; CD40 Antigens; Cell Line; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoglobulin G; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured

2009
Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
    Neoplasma, 2009, Volume: 56, Issue:6

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cell Transplantation

2009
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
    Journal of the National Cancer Institute, 2010, Jun-16, Volume: 102, Issue:12

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Bleomycin; Chlorambucil; Controlled Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Exercise; Hematinics; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multicenter Studies as Topic; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Quality of Life; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2010
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers.
    Leukemia research, 2011, Volume: 35, Issue:3

    Topics: Acetylation; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Drug Synergism; Epigenomics; Histones; Humans; Hydroxamic Acids; Immunophenotyping; L-Lactate Dehydrogenase; Leukemia, Lymphocytic, Chronic, B-Cell; Male; T-Lymphocytes; Testis; Th1 Cells; Tumor Cells, Cultured

2011
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidine.
    Leukemia research, 2011, Volume: 35, Issue:9

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Polarity; Cell Proliferation; Cells, Cultured; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Interferon-gamma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; STAT1 Transcription Factor; T-Lymphocytes; Th2 Cells

2011
Epigenetic inactivation of the miR-124-1 in haematological malignancies.
    PloS one, 2011, Apr-22, Volume: 6, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase 6; Epigenesis, Genetic; Female; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylation; MicroRNAs; Middle Aged; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; Young Adult

2011
Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:9

    Topics: Azacitidine; B-Lymphocytes; Blotting, Western; Cell Line; Chromatin; Chromatin Immunoprecipitation; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Promoter Regions, Genetic; Signal Transduction; Transcription Initiation Site; ZAP-70 Protein-Tyrosine Kinase

2012
Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    American journal of hematology, 2012, Volume: 87, Issue:4

    Topics: Apoptosis Regulatory Proteins; Azacitidine; Cell Division; Cell Line, Tumor; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Genes, Homeobox; Genes, Immunoglobulin; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoglobulin Heavy Chains; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Neoplasm Proteins; Sequence Analysis, DNA; Transcription Factors

2012
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
    BMC cancer, 2012, Jun-06, Volume: 12

    Topics: Antimetabolites, Antineoplastic; Azacitidine; beta Catenin; Cadherins; Cell Line, Tumor; Chromosome Mapping; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Protein Binding; Signal Transduction; Wnt Proteins

2012
TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-10, Volume: 23, Issue:17

    Topics: Antimetabolites, Antineoplastic; Azacitidine; B-Lymphocytes; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Helix-Loop-Helix Motifs; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Leukemia, Lymphocytic, Chronic, B-Cell; Prognosis; Promoter Regions, Genetic; Repressor Proteins; Somatic Hypermutation, Immunoglobulin; Transcription Factors; Treatment Outcome; Twist-Related Protein 1

2005
CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.
    Cancer research, 2006, Jan-15, Volume: 66, Issue:2

    Topics: Azacitidine; Cell Transformation, Neoplastic; CpG Islands; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Silencing; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Proteins; Proto-Oncogene Proteins; Signal Transduction; Wnt Proteins

2006
Downregulation of microRNAs-143 and -145 in B-cell malignancies.
    Cancer science, 2007, Volume: 98, Issue:12

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Cell Survival; Decitabine; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Lymphoma, B-Cell; MicroRNAs; RNA, Neoplasm; Tumor Cells, Cultured

2007
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:11

    Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Blotting, Southern; Daunorubicin; Decitabine; Dinucleoside Phosphates; DNA Methylation; Drug Resistance, Multiple; Epirubicin; Exons; Humans; Introns; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Promoter Regions, Genetic; Restriction Mapping; Transcription, Genetic; Tumor Cells, Cultured; Verapamil

1997
Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Acute Disease; Adult; Aged; Azacitidine; Computer Systems; Endogenous Retroviruses; Female; Gamma Rays; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Viral; Genes, gag; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Neoplastic Stem Cells; Phytohemagglutinins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic

2002